Oral and parenteral hypoglycaemics

Guidelines (10)
Tables (1)

Table: Antidiabetic Agents, Use in Renal Impairment

Dosing of diabetes drugs in patients with renal impairment.

Oral and parenteral hypoglycaemics in the News

Launch of new SGLT2 inhibitor increases choice in diabetes prescribing

Launch of new SGLT2 inhibitor increases choice in diabetes prescribing

Ertugliflozin (Steglatro) is a sodium glucose co-transporter...

Updated MIMS table helps prescribers adjust doses of diabetes combination products

Updated MIMS table helps prescribers adjust doses of diabetes combination products

Prescribers can now check the dose adjustments needed...

New once-weekly GLP-1 agonist for diabetes

New once-weekly GLP-1 agonist for diabetes

Ozempic (semaglutide) is a glucagon-like peptide-1...